Observational study of exposure to baricitinib during pregnancy in US-based administrative claims data (I4V-MC-B036)

12/12/2023
21/02/2025
EU PAS number:
EUPAS49806
Study
Planned
Documents
Study protocol
Initial protocol
English (475.25 KB - PDF) View document
Study results
Study report
Other information